MedTrace Logo

Brain Function and Structure in Cocaine Dependence

NCT02080832 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-12-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the role of brain MRI findings in predicting treatment outcomes among individuals with cocaine dependence.

Conditions

  • Cocaine Dependence

Interventions

DRUG

Citalopram

20 mg or 40 mg daily for 8 weeks

DRUG

Placebo

Placebo daily for 8 weeks

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Frederick G Moeller, M.D. · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02080832 on ClinicalTrials.gov